KAHNU CHARAN PANIGRAHI

Dr. KAHNU CHARAN PANIGRAHI

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
CPCh. Niranjan Patra
Ch. Niranjan Patra
RPRicha Priya
Richa Priya
SSSuryakanta Swain
Suryakanta Swain
GJGoutam Kumar Jena
Goutam Kumar Jena
KPKAHNU CHARAN PANIGRAHI
KAHNU CHARAN PANIGRAHI
DGDebashish Ghose
Debashish Ghose

1 June 2018 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
KPKAHNU CHARAN PANIGRAHI
KAHNU CHARAN PANIGRAHI
CPCh. Niranjan Patra
Ch. Niranjan Patra
GJGoutam Kumar Jena
Goutam Kumar Jena
DGDebashish Ghose
Debashish Ghose
JJJayashree Jena
Jayashree Jena
MSManoranjan Sahu
Manoranjan Sahu

1 April 2013 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
JSJammula Sruti
Jammula Sruti
CPChinam Niranjan Patra
Chinam Niranjan Patra
SSSuryakanta Swain
Suryakanta Swain
KPKAHNU CHARAN PANIGRAHI
KAHNU CHARAN PANIGRAHI
APAllupati Premananda Patro
Allupati Premananda Patro
MRMuddana Eswara Bhanoji Rao
Muddana Eswara Bhanoji Rao
A combination of melt-granulated dispersion and surface adsorption techniques was used to enhance the dissolution and tableting properties of cefuroxime axetil (CA). Gelucire 50/13 was used as the melt-dispersion carrier and Sylysia 350 was used to adsorb the melt dispersion. Solubility studies showed an 8-fold increase in solubility at a ratio of 1:1.5 for CA:Gelucire 50/13. The minimum quantity of Sylysia 350 required to achieve the desired flowability and compressibility was 0.5 parts of Sylysia 350 per unit of Gelucire 50/13. Phase solubility studies showed negative ΔGtr0 values for Gelucire 50/13 at various concentrations (2–10%, w/v), indicating the spontaneous nature of solubilization. FT-IR and DSC spectra exhibited drug-excipient compatibility. Molecular modeling by a computational method employing energy minimization revealed entrapment of CA in Gelucire 50/13. The total potential energy of CA (70.562kcal/mol) was reduced to 33.578kcal/mol after solid dispersion with Gelucire 50/13. P-XRD studies indicated that the presence of Sylysia 350 is less likely to promote the reversion of the amorphous CA to a crystalline state. In vitro dissolution studies demonstrated an improved dissolution rate, and drug release at 15min (Q15min) exhibited a 15-fold improvement. The rapidly dissolving CA tablets showed improved dissolution with improved tableting properties

1 October 2018 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
KPKAHNU CHARAN PANIGRAHI
KAHNU CHARAN PANIGRAHI
JJJayashree Jena
Jayashree Jena
GJGoutam Kumar Jena
Goutam Kumar Jena
CPCh. Niranjan Patra
Ch. Niranjan Patra
MRM.E. Bhanoji Rao
M.E. Bhanoji Rao

6 June 2019 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
KPKAHNU CHARAN PANIGRAHI
KAHNU CHARAN PANIGRAHI
CPCh. Niranjan Patra
Ch. Niranjan Patra
MRM. E. Bhanoji Rao
M. E. Bhanoji Rao

1 April 2015 in Powder Technology
Verified
Journal Article
Closed access
CPChinam Niranjan Patra
Chinam Niranjan Patra
SSSurya Kanta Swain
Surya Kanta Swain
SMSauravo Mahanty
Sauravo Mahanty
KPKAHNU CHARAN PANIGRAHI
KAHNU CHARAN PANIGRAHI